C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 207/12 (2006.01) A61K 31/4015 (2006.01) A61P 11/06 (2006.01)
Patent
CA 2552928
Compounds of formula (I) in free or salt form, wherein T, X, Y, U, R1, R2, m, n and p have the meanings as indicated in the specification, are useful for treating conditions mediated by CCR3. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
L'invention se rapporte à des composés de formule (I) sous forme libre ou sous forme de sel, qui peuvent servir à traiter des états dont la médiation est assurée par le récepteur CCR3. Dans ladite formule (I), T, X, Y, U, R?1¿, R?2¿,? ¿m, n et p sont tels que définis dans la description. Cette invention concerne en outre des compositions pharmaceutiques qui contiennent ces composés, ainsi que des procédés pour préparer lesdits composés.
Bhalay Gurdip
Dunstan Andrew
Glen Angela
Howe Trevor John
Mccarthy Clive
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Pyrrolidine derivatives acting as ccr3-receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidine derivatives acting as ccr3-receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine derivatives acting as ccr3-receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1845201